Surveillance of SARS-CoV-2 transmission in educational institutions, August to December 2020, Germany.


Journal

Epidemiology and infection
ISSN: 1469-4409
Titre abrégé: Epidemiol Infect
Pays: England
ID NLM: 8703737

Informations de publication

Date de publication:
22 09 2021
Historique:
pubmed: 23 9 2021
medline: 12 10 2021
entrez: 22 9 2021
Statut: epublish

Résumé

This study aims at providing estimates on the transmission risk of SARS-CoV-2 in schools and day-care centres. We calculated secondary attack rates (SARs) using individual-level data from state-wide mandatory notification of index cases in educational institutions, followed by contact tracing and PCR-testing of high-risk contacts. From August to December 2020, every sixth of overall 784 independent index cases was associated with secondary cases in educational institutions. Monitoring of 14 594 institutional high-risk contacts (89% PCR-tested) of 441 index cases during quarantine revealed 196 secondary cases (SAR 1.34%, 0.99-1.78). SARS-CoV-2 infection among high-risk contacts was more likely around teacher-indexes compared to student-/child-indexes (incidence rate ratio (IRR) 3.17, 1.79-5.59), and in day-care centres compared to secondary schools (IRR 3.23, 1.76-5.91), mainly due to clusters around teacher-indexes in day-care containing a higher mean number of secondary cases per index case (142/113 = 1.26) than clusters around student-indexes in schools (82/474 = 0.17). In 2020, SARS-CoV-2 transmission risk in educational settings was low overall, but varied strongly between setting and role of the index case, indicating the chance for targeted intervention. Surveillance of SARS-CoV-2 transmission in educational institutions can powerfully inform public health policy and improve educational justice during the pandemic.

Identifiants

pubmed: 34549699
doi: 10.1017/S0950268821002077
pii: S0950268821002077
pmc: PMC8503068
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e213

Références

Int J Infect Dis. 2020 Oct;99:57-61
pubmed: 32745628
J Glob Health. 2020 Dec;10(2):021104
pubmed: 33437465
Euro Surveill. 2020 Sep;25(36):
pubmed: 32914746
JAMA Pediatr. 2020 Oct 1;174(10):921-922
pubmed: 32401277
Euro Surveill. 2020 Dec;25(49):
pubmed: 33303065
Science. 2021 Feb 19;371(6531):
pubmed: 33323424
Proc Natl Acad Sci U S A. 2021 Jun 29;118(26):
pubmed: 34162708
PLoS One. 2021 Jun 2;16(6):e0252827
pubmed: 34077448
Lancet Infect Dis. 2021 Mar;21(3):344-353
pubmed: 33306981
Clin Infect Dis. 2021 Aug 2;73(3):e754-e764
pubmed: 33560412
Int J Infect Dis. 2020 Jul;96:288-290
pubmed: 32437933
Euro Surveill. 2020 May;25(21):
pubmed: 32489179
Lancet Child Adolesc Health. 2020 Nov;4(11):807-816
pubmed: 32758454
Clin Infect Dis. 2021 May 4;72(9):1493-1496
pubmed: 32584967
Clin Infect Dis. 2021 Mar 15;72(6):1055-1058
pubmed: 32584975
Lancet Glob Health. 2020 May;8(5):e644
pubmed: 32222161
MMWR Morb Mortal Wkly Rep. 2021 Feb 26;70(8):289-292
pubmed: 33630823
Dtsch Arztebl Int. 2020 Oct 20;117(48):828-829
pubmed: 33568260

Auteurs

Anja Schoeps (A)

Federal State Agency for Consumer & Health Protection Rhineland-Palatinate, Koblenz, Germany.
Heidelberg Institute of Global Heath, University Hospitals, Im Neuenheimer Feld 130.3, 69120Heidelberg, Germany.

Dietmar Hoffmann (D)

District Public Health Authority, Große Langgasse 29, 55116Mainz, Germany.

Claudia Tamm (C)

District Public Health Authority, Peter-Altmaier Platz 1, 56410Montabaur, Germany.

Bianca Vollmer (B)

District Public Health Authority, Peter-Altmaier Platz 1, 56410Montabaur, Germany.

Sabine Haag (S)

District Public Health Authority, Dörrhorststraße 36, 67059Ludwigshafen, Germany.

Tina Kaffenberger (T)

District Public Health Authority, Dörrhorststraße 36, 67059Ludwigshafen, Germany.

Kimberly Ferguson-Beiser (K)

District Public Health Authority, Ernst-Ludwig-Straße 36, 55232Alzey, Germany.

Berit Kohlhase-Griebel (B)

District Public Health Authority, Ernst-Ludwig-Straße 36, 55232Alzey, Germany.

Silke Basenach (S)

District Public Health Authority, Neumayerstraße 10, 67433Neustadt, Germany.

Andrea Missal (A)

District Public Health Authority, Trierer Straße 49-51, 66869Kusel, Germany.

Katja Höfling (K)

District Public Health Authority, In der Malzdürre 7, 57610Altenkirchen, Germany.

Harald Michels (H)

District Public Health Authority, Paulinstraße 60, 54292Trier, Germany.

Anett Schall (A)

District Public Health Authority, Arzheimer Str. 1, 76829Landau in der Pfalz, Germany.

Holger Kappes (H)

District Public Health Authority, Trierer Straße 1, 54634Bitburg, Germany.

Manfred Vogt (M)

Federal State Agency for Consumer & Health Protection Rhineland-Palatinate, Koblenz, Germany.

Klaus Jahn (K)

Ministry of Health, Federal State of Rhineland-Palatinate, Bauhofstraße 9, 55116Mainz, Germany.

Till Bärnighausen (T)

Heidelberg Institute of Global Heath, University Hospitals, Im Neuenheimer Feld 130.3, 69120Heidelberg, Germany.
Harvard Center for Population and Development Studies, Harvard University, Cambridge, USA.
Department of Global Health and Population, Harvard School of Public Health, Boston, USA.

Philipp Zanger (P)

Federal State Agency for Consumer & Health Protection Rhineland-Palatinate, Koblenz, Germany.
Heidelberg Institute of Global Heath, University Hospitals, Im Neuenheimer Feld 130.3, 69120Heidelberg, Germany.
Department of Infectious Diseases, Medical Microbiology and Hygiene, University Hospitals, Im Neuenheimer Feld 324, 69120Heidelberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH